glutathione synthase inhibitor Regulation of neuronal synthesis Appraising the Role of Astrocytes

Protocol of a phase ii randomized, multi-center, double-blind, placebo-controlled trial of S-Adenosyl methionine in participants with mild cognitive impairment or dementia due to Alzheimer's disease

Br J Clin Pharmacol 33:517520

Mutations in SLC40A1 in humans were first reported in 2001 and were found to cause autosomal dominant hemochromatosis (also known as ferroportin disease) ( The ferroptosis suppression function of CP is dependent on SLC40A1 (Shang et al., 2020)

Krishnamoorthy, [email protected] Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers

T., Kwon, J., Kim, H., & Cho, J